Wordt geladen...
Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow up
BACKGROUND: Imepitoin is a novel antiepileptic drug for the treatment of canine idiopathic epilepsy. The present study was conducted to demonstrate superior antiepileptic activity of a high dose of 30 mg/kg BID over a low dose of 1 mg/kg BID of imepitoin during 12 weeks of treatment under double bli...
Bewaard in:
| Gepubliceerd in: | BMC Vet Res |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4556053/ https://ncbi.nlm.nih.gov/pubmed/26330063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-015-0548-9 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|